2025年临床试验影像全球市场报告

预计未来几年临床试验成像市场规模将强劲成长。到 2029 年，这一数字将成长至 22.6 亿美元，年复合成长率（CAGR）为 9.3%。预测期内推动成长的因素包括慢性病的增加、研发支出的增加、老年人口的成长、临床研究的增加、受託研究机构的增加。预测期内的关键趋势包括增强成像模式的技术进步、市场参与者扩大其能力和产品供应的战略倡议、药物开发中采用基于成像的方法、分子成像和人工智能驱动的分析的进步以及产品创新。

预计慢性病盛行率的不断上升将在未来几年推动临床试验影像市场的扩张。慢性病是一种长期疾病，需要持续治疗，并严重影响日常活动和生活品质。这些慢性疾病的增加归因于空气污染、化学物质和毒素、生活方式的改变和遗传影响等因素。临床试验影像在有效监测患者、提供有关其病情和治疗结果的宝贵见解以及帮助提高患者的依从性和满意度方面发挥着至关重要的作用。例如，美国国家生物技术资讯中心（NCBI）在2023年1月预测，到2050年，患有至少一种慢性病的50岁及以上人群数量将增加99.5%，从2020年的7152万人增加到1.4266亿。因此，慢性病盛行率的不断上升推动了临床试验影像市场的成长。

临床试验影像市场的主要企业正专注于开发云端基础的成像工具，以提供改进的解决方案并提高临床试验的效率。这些工具利用云端运算技术来储存、管理和分析医学影像。例如，2023年3月，美国先进配电系统製造商Clarion宣布推出一款云端基础的创新影像检视器工具。该工具允许用户按需即时查看和互动高解析度影像，无需人工干预即可提供读取品质的存取。该工具简化了图像查看过程，并确保了简单、安全和合规的资料访问，使用户能够获得有关临床实验对象的宝贵见解。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、感染疾病、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球临床试验影像PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
• 最终用途产业分析
• 全球临床试验影像市场：成长率分析
• 全球临床试验影像市场表现：规模与成长，2019-2024
• 全球临床试验影像市场预测：规模与成长，2024-2029 年，2034 年
• 全球临床试验影像总体目标市场（TAM）

第六章市场区隔

• 全球临床试验影像市场（依产品及服务、绩效及预测），2019-2024 年、2024-2029 年、2034 年
• 服务
• 软体
• 全球临床试验影像市场（按模式、效能和预测），2019-2024 年、2024-2029 年、2034 年
• 电脑断层扫描
• 磁振造影
• 心臟超音波图
• 核子医学
• 正子断层扫描
• X射线
• 超音波
• 光学同调断层扫描
• 其他方式
• 全球临床试验影像市场：依应用、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 肿瘤学
• 神经病学
• 心臟病学
• 内分泌学
• 皮肤科
• 血液学
• 其他用途
• 全球临床试验影像市场依销售来源、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 直销
• 竞标出售
• 全球临床试验影像市场（依最终使用者、绩效及预测），2019-2024 年、2024-2029 年、2034 年
• 合约研究组织
• 製药和生物技术公司
• 医疗设备製造商
• 学术和政府研究组织
• 其他最终用户
• 全球临床试验影像市场，依服务类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 诊断影像服务
• 影像撷取服务
• 影像分析服务
• 影像管理和存檔服务
• 全球临床试验影像市场软体细分（按类型、实际及预测），2019-2024 年、2024-2029 年、2034 年
• 影像分析软体
• 影像处理软体
• 放射资讯系统（RIS）
• 影像存檔和通讯系统（PACS）

第七章 区域和国家分析

• 全球临床试验影像市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 全球临床试验影像市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

• 临床试验影像市场：竞争格局
• 临床试验影像市场：公司简介
  • Koninklijke Philips NV Overview, Products and Services, Strategy and Financial Analysis
  • Labcorp Drug Development Overview, Products and Services, Strategy and Financial Analysis
  • Icon Plc Overview, Products and Services, Strategy and Financial Analysis
  • PPD Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Syneos Health Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

• Charles River Laboratories
• Parexel International Corporation
• Clario
• Medpace Inc.
• Medidata Solution Inc.
• Biotelemetry Inc.
• WIRB-Copernicus Group
• ProScan Imaging LLC
• Invicro LLC
• Perspectum
• Radiant Sage LLC
• Worldcare Clinical LLC
• Intrinsic Imaging LLC
• Datatrak Inc.
• IXICO Plc

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

• 2029 年临床试验影像市场：提供新机会的国家
• 2029 年临床试验影像市场：细分市场将带来新机会
• 2029 年临床试验影像市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手的策略

第36章 附录

Clinical trial imaging involves utilizing medical imaging techniques such as magnetic resonance imaging (MRI), computed tomography (CT) scans, and X-rays to capture detailed internal images of participants during clinical trials. These images play a vital role in monitoring disease progression, evaluating treatment efficacy, and ensuring patient safety, making it an essential component in assessing the biological impact of new therapies and interventions.

The primary products and services in clinical trial imaging include services and software. Clinical trial imaging services entail providing specialized imaging techniques and methodologies to support the research and development phases of clinical trials. Various modalities encompass computed tomography, magnetic resonance imaging, echocardiography, nuclear medicine, positron emission tomography, X-ray, ultrasound, optical coherence tomography, among others. These services cater to various applications such as oncology, neurology, cardiology, endocrinology, dermatology, hematology, and others, distributed through direct sales and tender sales. End-users include contract research organizations, pharmaceutical and biotechnology companies, medical device manufacturers, academic and government research institutes, among others.

The clinical trial imaging market research report is one of a series of new reports from The Business Research Company that provides clinical trial imaging market statistics, including clinical trial imaging industry global market size, regional shares, competitors with a clinical trial imaging market share, detailed clinical trial imaging market segments, market trends, and opportunities, and any further data you may need to thrive in the clinical trial imaging industry. This clinical trial imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The clinical trial imaging market size has grown strongly in recent years. It will grow from $1.44 billion in 2024 to $1.58 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to increased sales and the distribution of clinical imaging software and services, increased risks of breast cancer, increased healthcare spending, rise in healthcare expenditure results in improved infrastructure, increased research and development spending by the pharmaceutical and biotechnological companies.

The clinical trial imaging market size is expected to see strong growth in the next few years. It will grow to $2.26 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to growing chronic diseases, rising research and development expenditures, an increasing geriatric population, a growing number of clinical studies, and an increasing number of contract research organizations. Major trends in the forecast period include technological advancements enhancing imaging modalities, strategic initiatives by market players to expand capabilities and offerings, adoption of imaging-based approaches in drug development, advancements in molecular imaging and AI-driven analysis, and product innovation.

The growing prevalence of chronic diseases is expected to drive the expansion of the clinical trial imaging market in the coming years. Chronic diseases are long-term conditions that require continuous medical attention and can significantly affect daily activities and quality of life. This increase in chronic diseases is attributed to factors such as exposure to air pollution, chemicals, and toxins, lifestyle changes, and genetic influences. Clinical trial imaging plays a crucial role in monitoring patients efficiently, providing valuable insights into their condition and the effects of treatments, which helps improve patient adherence and satisfaction. For example, the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, projected in January 2023 that by 2050, the number of individuals aged 50 and above with at least one chronic illness will rise by 99.5%, from 71.52 million in 2020 to 142.66 million. As a result, the increasing prevalence of chronic diseases is driving the growth of the clinical trial imaging market.

Major players in the clinical trial imaging market are focusing on developing cloud-based imaging tools to offer improved solutions and enhance clinical trial efficiency. These tools leverage cloud computing technology to store, manage, and analyze medical images. For instance, in March 2023, Clarion, a US-based manufacturer of advanced power distribution systems, introduced an innovative cloud-based image viewer tool. This tool enables real-time, on-demand viewing and manipulation of high-resolution images, providing read-quality access without the need for manual steps. It streamlines the image viewing process, ensuring easy, secure, and compliant data accessibility, empowering users to gain valuable insights into trial subjects.

In March 2023, Medica, a UAE-based medical company, acquired RadMD for an undisclosed sum. This strategic acquisition enables Medica to enter the clinical trials market, utilizing RadMD's expertise to enhance cost-efficiency and streamline drug and device development processes for pharmaceutical, biotech, and contract research organizations (CROs). RadMD, based in the US, specializes in offering clinical trial imaging solutions.

Major companies operating in the clinical trial imaging market are Koninklijke Philips N.V., Labcorp Drug Development, Icon Plc, PPD Inc., Syneos Health, Charles River Laboratories, Parexel International Corporation, Clario, Medpace Inc., Medidata Solution Inc., Biotelemetry Inc., WIRB-Copernicus Group, ProScan Imaging LLC, Invicro LLC, Perspectum, Radiant Sage LLC, Worldcare Clinical LLC, Intrinsic Imaging LLC, Datatrak Inc., IXICO Plc, Calyx Inc., Resonance Health Ltd., Anagram-ESIC SL

North America was the largest region in the clinical trial imaging market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical trial imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the clinical trial imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The clinical trial imaging market consists of revenues earned by entities by providing services such as image protocol development, data management and integration, image processing, and analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical trial imaging market also includes sales of analysis tools, clinical trial management systems, and compliance tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Clinical Trial Imaging Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on clinical trial imaging market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for clinical trial imaging ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The clinical trial imaging market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product And Services: Services; Software
• 2) By Modality: Computed Tomography; Magnetic Resonance Imaging; Echocardiography; Nuclear Medicine; Positron Emission Tomography; X-Ray; Ultrasound; Optical Coherence Tomography; Other Modalities
• 3) By Application: Oncology; Neurology; Cardiology; Endocrinology; Dermatology; Hematology; Other Applications
• 4) By Distributer: Direct Sales; Tender Sales
• 5) By End User: Contract Research Organizations; Pharmaceutical And Biotechnology Companies; Medical Device Manufacturers; Academic And Government Research Institutes; Other End-Users
• Subsegments:
• 1) By Services: Imaging Services For Diagnostics; Image Acquisition Services; Image Analysis Services; Image Management And Archiving Services
• 2) By Software: Imaging Software For Analysis; Image Processing Software; Radiology Information Systems (RIS); Picture Archiving And Communication Systems (PACS)
• Companies Mentioned: Koninklijke Philips N.V.; Labcorp Drug Development; Icon Plc; PPD Inc.; Syneos Health
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Clinical Trial Imaging Market Characteristics

3. Clinical Trial Imaging Market Trends And Strategies

4. Clinical Trial Imaging Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Clinical Trial Imaging Growth Analysis And Strategic Analysis Framework

• 5.1. Global Clinical Trial Imaging PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Clinical Trial Imaging Market Growth Rate Analysis
• 5.4. Global Clinical Trial Imaging Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Clinical Trial Imaging Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Clinical Trial Imaging Total Addressable Market (TAM)

6. Clinical Trial Imaging Market Segmentation

• 6.1. Global Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Services
• Software
• 6.2. Global Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Computed Tomography
• Magnetic Resonance Imaging
• Echocardiography
• Nuclear Medicine
• Positron Emission Tomography
• X-Ray
• Ultrasound
• Optical Coherence Tomography
• Other Modalities
• 6.3. Global Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Neurology
• Cardiology
• Endocrinology
• Dermatology
• Hematology
• Other Applications
• 6.4. Global Clinical Trial Imaging Market, Segmentation By Distributer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Direct Sales
• Tender Sales
• 6.5. Global Clinical Trial Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Contract Research Organizations
• Pharmaceutical And Biotechnology Companies
• Medical Device Manufacturers
• Academic And Government Research Institutes
• Other End-Users
• 6.6. Global Clinical Trial Imaging Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Imaging Services For Diagnostics
• Image Acquisition Services
• Image Analysis Services
• Image Management And Archiving Services
• 6.7. Global Clinical Trial Imaging Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Imaging Software For Analysis
• Image Processing Software
• Radiology Information Systems (RIS)
• Picture Archiving And Communication Systems (PACS)

7. Clinical Trial Imaging Market Regional And Country Analysis

• 7.1. Global Clinical Trial Imaging Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Clinical Trial Imaging Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Clinical Trial Imaging Market

• 8.1. Asia-Pacific Clinical Trial Imaging Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Clinical Trial Imaging Market

• 9.1. China Clinical Trial Imaging Market Overview
• 9.2. China Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Clinical Trial Imaging Market

• 10.1. India Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Clinical Trial Imaging Market

• 11.1. Japan Clinical Trial Imaging Market Overview
• 11.2. Japan Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Clinical Trial Imaging Market

• 12.1. Australia Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Clinical Trial Imaging Market

• 13.1. Indonesia Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Clinical Trial Imaging Market

• 14.1. South Korea Clinical Trial Imaging Market Overview
• 14.2. South Korea Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Clinical Trial Imaging Market

• 15.1. Western Europe Clinical Trial Imaging Market Overview
• 15.2. Western Europe Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Clinical Trial Imaging Market

• 16.1. UK Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Clinical Trial Imaging Market

• 17.1. Germany Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Clinical Trial Imaging Market

• 18.1. France Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Clinical Trial Imaging Market

• 19.1. Italy Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Clinical Trial Imaging Market

• 20.1. Spain Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Clinical Trial Imaging Market

• 21.1. Eastern Europe Clinical Trial Imaging Market Overview
• 21.2. Eastern Europe Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Clinical Trial Imaging Market

• 22.1. Russia Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Clinical Trial Imaging Market

• 23.1. North America Clinical Trial Imaging Market Overview
• 23.2. North America Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Clinical Trial Imaging Market

• 24.1. USA Clinical Trial Imaging Market Overview
• 24.2. USA Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Clinical Trial Imaging Market

• 25.1. Canada Clinical Trial Imaging Market Overview
• 25.2. Canada Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Clinical Trial Imaging Market

• 26.1. South America Clinical Trial Imaging Market Overview
• 26.2. South America Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Clinical Trial Imaging Market

• 27.1. Brazil Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Clinical Trial Imaging Market

• 28.1. Middle East Clinical Trial Imaging Market Overview
• 28.2. Middle East Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Clinical Trial Imaging Market

• 29.1. Africa Clinical Trial Imaging Market Overview
• 29.2. Africa Clinical Trial Imaging Market, Segmentation By Product And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Clinical Trial Imaging Market, Segmentation By Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Clinical Trial Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Clinical Trial Imaging Market Competitive Landscape And Company Profiles

• 30.1. Clinical Trial Imaging Market Competitive Landscape
• 30.2. Clinical Trial Imaging Market Company Profiles
  • 30.2.1. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Labcorp Drug Development Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Icon Plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. PPD Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Syneos Health Overview, Products and Services, Strategy and Financial Analysis

31. Clinical Trial Imaging Market Other Major And Innovative Companies

• 31.1. Charles River Laboratories
• 31.2. Parexel International Corporation
• 31.3. Clario
• 31.4. Medpace Inc.
• 31.5. Medidata Solution Inc.
• 31.6. Biotelemetry Inc.
• 31.7. WIRB-Copernicus Group
• 31.8. ProScan Imaging LLC
• 31.9. Invicro LLC
• 31.10. Perspectum
• 31.11. Radiant Sage LLC
• 31.12. Worldcare Clinical LLC
• 31.13. Intrinsic Imaging LLC
• 31.14. Datatrak Inc.
• 31.15. IXICO Plc

32. Global Clinical Trial Imaging Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Clinical Trial Imaging Market

34. Recent Developments In The Clinical Trial Imaging Market

35. Clinical Trial Imaging Market High Potential Countries, Segments and Strategies

• 35.1 Clinical Trial Imaging Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Clinical Trial Imaging Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Clinical Trial Imaging Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer